Protracted low-dose effects on human endothelial cell proliferation and survival in vitro reveal a selective antiangiogenic window for various chemotherapeutic drugs.

Guido Bocci(University of Pisa), Robert S. Kerbel(Sunnybrook Health Science Centre), K. C. Nicolaou(Scripps Research Institute)
PubMed
December 1, 2002
Cited by 445


Related Papers